alexa Interim recommendations for the surveillance of drug resistance in tuberculosis


Clinical Microbiology: Open Access

Author(s): World Health Organization

Abstract Share this page

Revised drug resistance surveillance guidelines will become available later this year. In the interim, this document has been drafted to provide guidance on the areas that will be updated in the forthcoming guidelines. These interim recommendations build on guidelines that have already been published in 20031 . It is important to note that these recommendations are conceptual. For practical guidance please refer to the previous guidelines and/or a technical consultant that can provide assistance in designing the survey protocol and advising on specific logistics. There are three fundamental principles of the WHO/IUATLD Global project on drug resistance surveillance. These interim recommendations follow these principles: 1. Survey sample must represent the population under study. 2. TB patients must be differentiated by previous history of treatment. 3. Laboratory results must be quality controlled. **4. Other areas of consideration (coordination, ethics, quality assurance, budget).

  • To read the full article Visit
  • Open Access
This article was published in WHO and referenced in Clinical Microbiology: Open Access

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version